PH-797804, (AXIAL S)-(-)-
Neuralgia, Postherpetic
PfizerSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
19 Active assets in the Neuralgia, Postherpetic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Seoul National University Hospital | Phase 4 | BBB |
Capsaicin Astellas Pharma Europe Ltd. | Phase 4 | BBB |
Pregabalin Neurodawn Pharmaceutical Co., Ltd. | Phase 4 | BBB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- University of Medicine and Pharmacy at Ho Chi Minh City | Phase 4 | BBB |
Capsaicin Astellas Pharma Europe Ltd. | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →